Chief Scientific Officer
Dr. Justin Grant has over twenty years of experience in leading the development of medical and pharmaceutical products; he has the expertise required for the growth and development of Psyence’s scientific divisions. He has held leadership roles in some of Canada’s top research and medical institutions such as the University Health Network (UHN). From 2007-2019, he served as Staff Scientist and the Research Program Manager of the world-renowned Spatio-Temporal Targeting and Amplification of Radiation Response (STTARR) Innovation Centre with Princess Margaret Cancer Centre. From 2019-2021, he was the Executive Vice President of Scientific Affairs for Avicanna Inc., where he focused on the development and commercialization of advanced medical cannabis products globally. He has held academic appointments including Assistant Professor at the University of Toronto’s Faculty of Pharmacy and Affiliated Faculty member of the Techna. His academic accomplishments include a PhD in Pharmaceutical Sciences (University of Toronto), where he published and patented several sustained drug release formulations. He completed his Executive Master of Business from Rotman School of Management (University of Toronto); and was the recipient of the Rotman Dean’s Award for Academic Excellence. Dr. Grant is currently an Instructor at Rotman for Corporate Strategy and Healthcare Innovation.